02-01-2021 04:58 PM | Source: Angel Broking Ltd
Pharma sector based on Budget 2021-22 By Yash Gupta, Angel Broking
News By Tags | #5948 #5238 #607 #642 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Below are View on Pharma sector based on Budget 2021-22 By Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd

Can vaccines be a game changer for the Pharma industry?

The Budget outlay for Health and Wellbeing is 2,23,846 crores in BE 2021-22 as against this year’s BE of 94,452 crores an increase of 137 percentage. The Pneumococcal Vaccine, a Made in India product, is presently limited to only 5 states and will be rolled out across the country. This will avert more than 50,000 child deaths annually. Along with this separate 35,000 crores for Covid-19 vaccine in BE 2021-22 and if required more then committed to provide further funds also.

This will be positive for Cadila Healthcare and Pfizer Ltd.

 

Above views are of the author and not of the website kindly read disclaimer